The company also announced the receipt of an IDE from the U.S. Food and Drug Administration, to conduct a clinical study examining the combination of Alpha DaRT and first-line chemotherapy in 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback